http://media.wix.com/ugd/f7710c_e8efa5d ... bcb7d5.pdf
Test now available at following locations:
Internal Medicine of Northern Virginia
1860 Town Center Drive #230
Reston, Virginia 20190
Phone 703 709-1119
The Nanotrap® Lyme Antigen (LA) Test is a novel, high sensitivity, DIRECT test for Lyme that will provide valuable information to assist a physician in diagnosing and treating Lyme disease at most stages of infection.
Unlike other clinical Lyme disease tests that are INDIRECT, the Nanotrap® LA Test is a non-invasive test that provides highly sensitive and specific direct detection of the Lyme antigen, Borrelia burgdorferi (Bb), in a patient’s urine sample.
The Nanotrap® LA Test can provide valuable information, at anytime in the infection cycle, about the presence of the Bb antigen when used at the time of initial infection, during and after a course of treatment, and in some cases of recurrent disease.
http://www.ceresnano.com/#!nanotrap-lyme-test/c64dLyme Disease - Lyme disease is a bacterial infection carried by ticks. Approximately 30,000 people are diagnosed with Lyme disease in the US every year, a number which has almost doubled in the past decade. Lyme disease is most prominent in the Northeast and Midwest, but cases of Lyme have been confirmed in every state, and it is also becoming prevalent on other continents. Lyme disease is well known for having symptoms that are very similar to those of other diseases. Some of the most common symptoms include a "bulls-eye" rash, fatigue and flu-like symptoms. If left untreated, the disease can seriously affect the heart and central nervous system which can lead to heart inflammation, meningitis, arthritis, memory loss and even paralysis.
Unlike the Nanotrap® LA Test, current serological tests for Lyme disease are indirect tests: they measure the body’s immune response and not the disease itself. These other tests are highly unreliable and can delay diagnosis. After initial infection, the body produces antibodies to fight the invading bacteria. Serological tests may detect these blood-borne antibodies, however it can take weeks after initial infection before antibody levels are sufficient to provide a result. Also, if a test is run before the required antibody levels are reached, the patient can receive a false negative result. Even if a positive diagnosis is achieved, antibody levels remain high despite successful treatment, leading to false positive results and prolonged treatment periods
The Ceres' Nanotrap® Lyme Antigen Test uses the Nanotrap® technology to directly measure Lyme antigens in urine using a Western Blot format. The Nanotrap® test is designed to provide high sensitivity and accuracy, delivering confident results at the earliest stages of infection. The Nanotrap® LA Test uses a direct approach and tests for the Lyme bacterial antigen, which is present in the body and can be detected within days of initial infection. Conversely, the Nanotrap® LA Test will provide a negative result indicating no presence of the antigen if the infection has been eliminated with effective treatment.